Light-Scattering Spectroscopy for Detection of Breast Cancer
Conditions
Healthy, no Evidence of Disease - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Conditions: official terms
Breast Neoplasms
Study Type
Interventional
Study Phase
N/A
Study Design
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Intervention
Name: light-scattering spectroscopy
Type: Procedure
Overall Status
Recruiting
Summary
This pilot clinical trial studies light-scattering spectroscopy in finding disease in patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering spectroscopy, may help find and diagnose breast cancer
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate whether light-scattering spectroscopy can reliably distinguish between two subject groups: those with clinical stage II or stage III breast cancer and those without breast cancer.

OUTLINE: Patients undergo light-scattering spectroscopy of the breast in addition to standard of care as it relates to screening for breast cancer or treatment of breast cancer.
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Participants who are breast cancer free (mammogram "negative" within 1 month of testing) with the absence of clinical suspicion of breast cancer on physical exam or with clinical stage II or stage III breast cancer. PLEASE NOTE: Recruitment for this study is only limited to patients who are scheduled for a mammogram at USC. There is no compensation to participants.

- Provision of informed consent prior to any study-related procedures

Exclusion Criteria:

- Females with tattoos on either or both breasts

- Females with nipple piercings on either or both breasts

- Females with skin piercings (aka microdermal anchor surface or microdermal piercings) in either or both breasts

- Females unable to provide informed consent

- Females s/p treatment for breast cancer
Location
USC Norris Comprehensive Cancer Center
Los Angeles, California, United States
Status: Recruiting
Contact: Victoria Soto - 323-226-6384 - victoria.soto@med.usc.edu
Start Date
November 2012
Completion Date
November 2016
Sponsors
University of Southern California
Source
University of Southern California
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page